Patients with diabetic retinopathy should be monitored according to standard diabetes care guidelines, as rapid improvement in glycemic control has been associated with temporary worsening of retinopathy in some studies, though this is not a tirzepatide-specific labeled warning
March 3rd, 2026: Federal Judge Appoints Leadership for GLP1 Vision Loss Lawsuits Multiple lawsuits alleging vision loss from GLP1 drugs, including Ozempic, Wegovy, and Mounjaro have been consolidated into a multidistrict litigation in the Eastern District of Pennsylvania, the same court responsible for handling GLP-1 lawsuits involving gastrointestinal injuries
For mothers navigating the complex intersection of GLP-1 therapy and breastfeeding, having access to comprehensive, up-to-date research, dosage calculators , and protocol guidance can make the difference between informed confidence and anxious guessing
NAION Management and Prognosis in GLP-1 Drug Users For high-risk patients using GLP-1 drugs, close monitoring is essential